Personalized medicine, says this article in T he Scientist , could breathe new life into failed drug candidates . “If Merck could have known in advance who would have cardiovascular problems from Vioxx, they may not have had to withdraw it from the market,” Personalized Medicine Coalition’s Edward Abrahams says.
New Trial for Valley Family's Lawsuit over Vioxx
Family Sued Merck after 71 year-old Man Died of Heat Attack
Discovery Labs, thrice at the altar, awaits FDA decision
WARRINGTON — No one has to tell Robert J. Capetola how hard it is to get a new product approved by the Food and Drug Administration in the post-Vioxx era.
April 6 (Bloomberg) -- Merck & Co. shares fell as much as 5.6 percent in Germany after a New Jersey jury ruled the drugmaker must pay at least $4.5 million to a 77-year-old man who claimed its painkiller Vioxx caused his heart attack. Read more here
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved